Compare Duolingo Inc (DUOL) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance

Duolingo (DUOL) trades at $140.1, down 5.17% over the past day, amid mixed technical signals but strong fundamental performance. The stock shows a bullish moving average trend and neutral oscillators, with key support near $143. Financially, the company reported robust revenue growth, reaching $1.04 billion in 2025, with a net income margin of 35.87% and consistent earnings beats in recent quarters. Recent news highlights CEO share sales and AI-driven growth initiatives, contributing to investor attention.

The outlook for DUOL remains positive given its earnings momentum and expanding user base, though risks include insider selling and competitive pressures. Analyst consensus leans bullish with a $142.50 price target, suggesting modest upside from current levels, supported by institutional interest and solid cash flow generation.

Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.

The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.